Cannabis Attorney Bob Hoban Joins Aurelius Data
Advisory Board

August 9, 2020        

Missoula, MTAurelius Data, the first global patient perception big data company in plant-based medicines, is pleased to announce Bob Hoban, the preeminent cannabis attorney is the newest member of the Aurelius Data Advisory Board. 

“Bob Hoban is widely regarded around the country as one of the foremost experts in the cannabis industry and has become a global leader championing responsible policy that benefit governments and their entrepreneurs. We could not be happier to working with a man who has helped to craft this space and understands the need for research to advance plant medicines for the betterment of society,” said Aurelius Data CEO Julie Armstrong.

“Aurelius Data understands the need to standardize data and compile it to build the research necessary to create new treatments and medicines. Wellness will be first and foremost in many people’s minds after we come out of this pandemic and we are going to need groups like Aurelius Data who are striving to make sure patients have the information they need for their wellness journeys,” said Bob Hoban.

Hoban has consistently been recognized as one of the most influential people in the global cannabis industry by a variety of organizations and publications over the course of the past ten-plus years.  Since 2013, Bob has achieved the Martindale-Hubbell AV Preeminent Peer Review Rating, awarded to only those lawyers with the highest ethical standards and professional ability.  He was recently named a “Cannabis Law Trailblazer” by the National Law Journal, and he has been consistently recognized as one of “Denver’s Top Cannabis Lawyers for nearly a decade.    

From 2010-2016, Bob served as one of the Nation’s first cannabis policy instructors at the University of Denver, where he regularly lectured regarding cannabis topics (government regulations, public policy, and research-based policy courses), and where he led a University-sanctioned research practicum concerning the efficacy of marijuana regulation; the first of its kind in the U.S.  He then taught several international travel courses concerning the emergence of the global cannabis industry. Because of this academic background, Bob has been asked to work with dozens of governments across the U.S., Asia, the E.U., and Latin America (over thirty different countries) on crafting their commercial cannabis public policy solutions (legislation and regulations). And he has served on a variety of national, state, and local task forces related to cannabis policy issues.         

In 2008, he deliberately constructed the Hoban Law Group (HLG) to become the world’s leading full-service commercial cannabis industry law firm; the first of its kind  Since that time, HLG has indeed become the world’s leading cannabis industry law firm, with offices in seventeen states and ten nations abroad, and over fifty attorneys who specialize in all aspects of the commercial practice surrounding the cannabis industry. For nearly ten years, HLG has represented the cannabis industry’s titans in every aspect of the commercial cannabis industry around the world. And he is largely responsible for the establishment and growth of the CBD industry due to his legal strategies, litigation matters, and policy efforts executed on behalf of HLG clients.    

####

Aurelius Data, Inc is a patient use and perception focused big data company. We deliver insights from analyzing the intersection of science, user perception, product use, chemical analysis, and the users’ reported medical condition and symptom resolution. Our mission is to put the patient first, by increasing confidence and understanding, drive product development, boost customer retention, reveal cutting edge IP discoveries, and provide immediate, tangible value to every user.  

Our anonymously gathered data follows HIPPA compliance and immediately benefits the user through a continuous feedback loop of user input, product recommendations and community connection. Our vision is to go beyond the strain and create a reliable product use and efficacy reference for cannabis users.   

Contact: Gretchen Gailey, Media & PR Advisor, Aurelius Data MediaInquiries@aureliusdata.com, 202.489.3821